AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Long-Term Investments (2020 - 2026)

Updated

AbCellera Biologics (ABCL) posted Long-Term Investments of $65.23 million for Q2 2026, down 27.8% from $90.37 million a year earlier and down 0.1% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Long-Term Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, AbCellera Biologics' Long-Term Investments came in at $62.58 million, down 24.0% from FY2024.

  • Annual Long-Term Investments shows a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
  • In prior years, AbCellera Biologics' Long-Term Investments was $82.3 million in FY2024 (+24.8%), $65.94 million in FY2023 (-9.1%), $72.52 million in FY2022 (+44.1%) and $50.31 million in FY2021 (+161.4%).
  • Quarterly Long-Term Investments has run from a low of $47.51 million in Q3 2021 to a high of $93.3 million in Q3 2025 over five years.
  • On a year-over-year basis, Long-Term Investments has declined in each of the last three quarters, with growth averaging 3.8% over the last eight quarters.
  • The strongest year-over-year quarter for Long-Term Investments in the past five years was Q4 2021, with growth of 161.4%; the weakest was Q2 2026, with a decline of 27.8%.
  • According to Business Quant data, Long-Term Investments for the three prior quarters was $65.31 million (Q1 2026), $62.58 million (Q4 2025) and $93.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 266.00 Mn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 2.62 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 5.79 Bn
10 AbCellera Biologics 3.89 Bn 3.89 Bn - 65.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.23 Mn
Mar 31, 2026 65.31 Mn
Dec 31, 2025 62.58 Mn
Sep 30, 2025 93.30 Mn
Jun 30, 2025 90.37 Mn
Mar 31, 2025 81.57 Mn
Dec 31, 2024 82.30 Mn
Sep 30, 2024 84.08 Mn
Jun 30, 2024 76.06 Mn
Mar 31, 2024 71.59 Mn
Dec 31, 2023 65.94 Mn
Sep 30, 2023 62.89 Mn
Jun 30, 2023 58.79 Mn
Mar 31, 2023 57.58 Mn
Dec 31, 2022 72.52 Mn
Sep 30, 2022 66.72 Mn
Jun 30, 2022 65.82 Mn
Mar 31, 2022 58.88 Mn
Dec 31, 2021 50.31 Mn
Sep 30, 2021 47.51 Mn
API Access

AbCellera Biologics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABCL&period=max&api_key=YOUR_API_KEY